This announcement is a separate document:
康寧傑瑞製藥-B：內幕消息公告 - JSKN003在澳大利亞進行的治療HER2表達晚期實體瘤的I期臨床研究的初步結果
ALPHAMAB-B: INSIDE INFORMATION ANNOUNCEMENT - PRELIMINARY RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003 IN AUSTRALIA FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLID TUMORS
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.